4B-MAR
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.[1]
See also
- 2C-B-aminorex
- 2F-MAR
- 4C-MAR
- 4,4'-DMAR
- 4'-Fluoro-4-methylaminorex
- 4-Methylaminorex
- MDMAR
- 3-Bromomethylphenidate
- 4-Bromoamphetamine
- 4-Bromomethcathinone
- RTI-51
References
- ^ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18). Basel, Switzerland: 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.